Company profile for Synaffix

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our clinical-stage technology platform enables ADCs that are safer, more effective and easier to manufacture. Formed in 2010, Synaffix BV is a Netherlands-based biotechnology company exclusively focused on continued advancement of our best-in-class, clinical-stage antibody-drug conjugate (ADC) technology platform. As a leading innovator in the field of ADCs offering absolute versatility and state-of-the-art solutions, our visi...
Our clinical-stage technology platform enables ADCs that are safer, more effective and easier to manufacture. Formed in 2010, Synaffix BV is a Netherlands-based biotechnology company exclusively focused on continued advancement of our best-in-class, clinical-stage antibody-drug conjugate (ADC) technology platform. As a leading innovator in the field of ADCs offering absolute versatility and state-of-the-art solutions, our vision is to become the preferred partner in the development of these complex biological therapeutics and realize our ambition – connect to cure.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Netherlands
Address
Address
Kloosterstraat 9 5349 AB Oss, Netherlands
Telephone
Telephone
+31 88 022 4505
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/abl-bio-taps-into-synaffix-adc-technology-to-accelerate-development-of-bispecific-adc-products-301924608.html

PR NEWSWIRE
04 Nov 2025

https://www.prnewswire.com/news-releases/lonzas-synaffix-collaborates-with-qurient-therapeutics-to-enable-development-of-dual-payload-adc-302566442.html

PR NEWSWIRE
25 Sep 2025

https://www.businesswire.com/news/home/20250313963846/en/SOTIO-Expands-ADC-Pipeline-and-Synaffix-Collaboration-to-Develop-Two-Novel-Bispecific-Candidates-SOT112-and-SOT113

BUSINESSWIRE
13 Mar 2025

https://www.fiercebiotech.com/biotech/lonzas-synaffix-adds-boehringer-ingelheim-its-constellation-partners-1b-adc-technology-pact

FIERCE BIOTECH
10 Jan 2025

https://www.indianpharmapost.com/news/synaffix-and-mitsubishi-tanabe-pharma-ink-license-agreement-for-adc-technology-16649

INDPHARMAPOST
10 Jan 2025

https://www.prnewswire.com/news-releases/synaffix-and-mitsubishi-tanabe-pharma-sign-license-agreement-for-adc-technology-302346911.html

PR NEWSWIRE
09 Jan 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Contact Synaffix and get a quotation

Synaffix is a supplier offers 5 products (APIs, Excipients or Intermediates).

Find a price of SYNSTATIN E bulk with DMF offered by Synaffix

Find a price of UDP-AZIDOSUGAR bulk with DMF offered by Synaffix

Find a price of SYNEAMICIN G bulk with DMF offered by Synaffix

Find a price of ENDOGLYCOSIDASE SH (ENDOSH) bulk with DMF offered by Synaffix

Find a price of GLYCOSYLTRANSFERASE (GT) bulk with DMF offered by Synaffix

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty